Lab data

TB-500 test results: how often vials pass lab testing

More recent TB-500 samples failed lab testing than passed. Here are the numbers, the fragment versus full-length question, and where HHS's October 2026 draft policy leaves it.

12 November 2026 3 min read By Peptide AI Editorial policy

Of the last 195 TB-500 samples with a result in Finnrick's public lab-testing database, 84 passed and 111 failed: 43 percent of TB-500 test results were a pass. Another 5 came back incomplete and are left out. Finnrick has published 299 TB-500 tests from 61 sellers since 16 May 2025.

TB-500 is a synthetic fragment of thymosin beta-4, the full 43-amino-acid natural protein. The full-length protein has some human clinical research, mostly in eye and heart studies. The fragment sold as a research chemical has mostly animal and lab evidence, and its human benefit is not established.

The short version

  • 43 percent of recent samples passed. 84 passed and 111 failed, of the last 195 with a result.
  • It is not FDA-approved. HHS's October 2026 draft policy would let licensed pharmacies compound it on a prescription under strict conditions. It is a draft.
  • A pass is a narrow result. It covers identity, purity and fill for the vial that was tested. It does not cover endotoxin, sterility or the next batch.
  • We do not name sellers. The numbers describe the market, not any one shop.

TB-500 test results in numbers

MeasureTB-500
Published tests299
Sellers with at least one test61
First and latest test16 May 2025 to 2 Nov 2026
Recent results counted195 (5 incomplete left out)
Passed84
Failed111
Pass rate43%
Rank by pass rate12 of 14 on our peptide test results page

Figures from Finnrick's public TB-500 page, checked on 12 November 2026. They will change as new results come in.

What counts as a pass or a fail

These figures use Finnrick's "Purity focus" standard, the one its public pages show. A sample passes when its purity is at least 99.5 percent and the amount in the vial is within 35 percent of the label. A sample that turns out to be a different molecule fails under every standard Finnrick uses. Endotoxin testing is not required under this standard, so a pass says nothing about endotoxin or sterility.

The pass rate counts passes and fails among the most recent results on Finnrick's public page, up to 200, and leaves out tests that came back incomplete. Finnrick says it sources samples from sellers and sends them to third-party labs, with HPLC as the main method. Its methodology page has the detail.

Is TB-500 FDA-approved?

No (see our TB-500 page). FDA took TB-500 out of Category 2 in April 2026, and its compounding advisory committee recommended it for the 503A bulks list on 23 July 2026 (what that vote means). HHS's draft enforcement discretion policy, published on 30 October 2026, covers TB-500 in specified forms and routes. Pharmacies would need a prescription, a registered source and a valid certificate of analysis. It is a draft, and it does not cover research-use-only products.

More fails than passes, and a naming problem

Of the last 195 TB-500 samples with a result, 111 failed and 84 passed. Finnrick has published 299 TB-500 tests from 61 sellers since 16 May 2025.

Names add confusion. "TB-500" and "thymosin beta-4" get used loosely for both the fragment and the full protein, which are different molecules. An identity test is the only way to know which one a vial holds, and a vial that is not what its label says fails outright.

Before you buy TB-500

There is no approved TB-500 product, and the pharmacy route in the HHS draft does not exist until the policy is final.

Before any order, three checks come first: the steps in how to vet a peptide supplier, an independent result for your own lot (how to get peptides tested), and the legal picture in is it legal to buy peptides. Products sold as research use only are not FDA-approved drugs, and a passing test does not make one safe to use.

Peptide AI is building a marketplace with two ways to buy: on a prescription through licensed telehealth, for what can legally be prescribed, or from vetted suppliers with an independent lab report you read before you order. It is not open yet. Early access is here.

Questions people ask

What percentage of TB-500 fails lab testing?

In Finnrick's public test database, 111 of the last 195 TB-500 samples with a result failed, which is 57 percent, and 84 passed. Tests that came back incomplete are left out.

Is TB-500 FDA-approved?

It is not FDA-approved. HHS's October 2026 draft policy would let licensed pharmacies compound it on a prescription under strict conditions. It is a draft.

Does a passing lab test mean TB-500 is safe?

No. A pass means the sample matched its label on identity, purity and fill under one standard. It does not cover endotoxin, sterility, other vials, or whether TB-500 is safe or does anything in people.

Is TB-500 the same as thymosin beta-4?

No. Thymosin beta-4 is the full 43-amino-acid protein. TB-500 is a synthetic fragment of it. The names are often used loosely, and only an identity test tells you which one a vial contains.

Sources

  1. Methodology, Finnrick, accessed 12 November 2026
  2. TB-500 product page and public test history, Finnrick, accessed 12 November 2026
  3. HHS announces interim enforcement discretion for section 503A compounding with certain peptide bulk drug substances, Venable LLP, 6 November 2026
Free on iOS and Android

Log it once. See it all on one timeline.

Doses, food, training, labs, sleep and scans on one timeline. On iOS and Android.

The PeptideAI protocol screen with a weekly GLP-1 dose on it.